NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Welcome to Erlend B. Smeland's group:

Lymphomas & Lymphocyte biology

 
From left: Marianne B. Eide, Erlend B. Smeland, Maren Bakkebø, Olav Yri, Kanutte Huse, Lise Forfang, May K. Bredahl, Vera Hilden, June H. Myklebust, Nicole Bethge, Morten Oksvold.
From left: Marianne B. Eide, Erlend B. Smeland, Maren Bakkebø, Olav Yri, Kanutte Huse, Lise Forfang, May K. Bredahl, Vera Hilden, June H. Myklebust, Nicole Bethge, Morten Oksvold.

The main focus of our research is the molecular characterization of B cell lymphomas. Lymphomas are cancers derived from the cells of the immune system, and most often they arise from B- or T-cells in the lymph nodes. By the means of high throughput analysis of gene expression, genomic and epigenetic alterations in lymphoma samples we aim to elucidate oncogenetic mechanisms in lymphoma development. We also aim to identify prognostic markers and characterize biologically different subgroups of lymphoma. In functional studies on lymphoma cell lines and normal B-cells we focus on the effects of BMP- and TGF-beta signaling in lymphomas.

An overview of our key achievements can be found here.

The group is a member of Center for Cancer Biomedicine.

 
 
 

Contact information:

Department of Immunology, Institute for Cancer Research
The Norwegian Radium Hospital
Montebello
0310 Oslo, Norway

Phone:+47 22 78 14 17 (Smeland)
 +47 22 78 12 66 (Secretary)
 +47 22 93 40 00 (switchboard)
Fax:+47 22 78 13 45

Email to E. Smeland: ebs@rr-research.no

 

 
>> Print this page  [6950 visits]